-
Mashup Score: 0FY24 May Evergreen LP - Heart.org - 3 hour(s) ago
Your gift now to the American Heart Association will help save lives by funding pioneering medical research, education and prevention information and more. For 100 years the American Heart Association has been leading the fight to save lives from heart disease and stroke. We’ve invested more than $5 billion in heart and brain research, leading to the development of the artificial heart valve, the defibrillator, and even CPR. Countless lives have been saved. But we are still losing someone every 34
Source: pages.heart.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Pulsed Field Ablation for Incessant Scar-Related Ventricular Tachycardia: First U.S. Report - 4 hour(s) ago
70 y/o woman with a history of ischemic cardiomyopathy with ejection fraction of 20% due to a large healed anteroapical infarction. She had previously undergone three prior endocardial radiofrequency ablations for scar-related ventricular tachycardia (VT) with the most recent procedure at our center 4 months prior to the current hospital presentation. During that procedure, three zones of deceleration were identified, and ablation terminated two VT morphologies along the septal aspect of the scar and the patient was rendered noninducible from multiple sites of stimulation within the left ventricle.
Source: www.heartrhythmjournal.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer - 5 hour(s) ago
Objectives Long-term follow-up of patients treated with trastuzumab largely focuses on those with reduced left ventricular ejection fraction (LVEF) on treatment completion. This study sought to evaluate the prevalence of cardiovascular risk factors, overt cardiovascular disease and cardiac imaging abnormalities using cardiac magnetic resonance (CMR), in participants with normal LVEF on completion of trastuzumab±anthracycline therapy at least 5 years previously. Methods Participants with human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab±anthracycline ≥5 years previously were identified from a clinical database. All participants had normal LVEF prior to, and on completion of, treatment. Participants underwent clinical cardiovascular evaluation, ECG, cardiac biomarker evaluation and CMR. Left ventricular systolic dysfunction (LVSD) was defined as LVEF <50%. Results Forty participants were recruited between 15 March 2021 and 19 July 2022. Median time
Source: heart.bmj.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: - 5 hour(s) ago
AbstractBackgroundIncrementing numbers of patients treated for attention-deficit/hyperactivity disorder (ADHD) call for scrutiny concerning long-term drug-safety.ObjectivesThis study aims to invest…
Source: www.jacc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 6
BACKGROUND: Pericytes are capillary-associated mural cells involved in the maintenance and stability of the vascular network. Although aging is one of the main risk factors for cardiovascular disease
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Predicting Post-Infarct Ventricular Tachycardia by Integrating Cardiac MRI and Advanced Computational Reentrant Pathway Analysis - 7 hour(s) ago
Implantable cardiac defibrillator (ICD) implantation can protect against sudden cardiac death (SCD) after a myocardial infarction. However, improved risk stratification for device requirement is still needed.
Source: www.heartrhythmjournal.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
You will be using this platform to submit your abstract and contact information for the ACC Quality Summit. Please create an account by selecting “Join Now” below. If you have submitted an abstract for a past ACC Quality Summit, you will still need to join as a new user. Click ‘Join Now’ to begin your first submission.
Source: www.abstractscorecard.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer - 8 hour(s) ago
Objectives Long-term follow-up of patients treated with trastuzumab largely focuses on those with reduced left ventricular ejection fraction (LVEF) on treatment completion. This study sought to evaluate the prevalence of cardiovascular risk factors, overt cardiovascular disease and cardiac imaging abnormalities using cardiac magnetic resonance (CMR), in participants with normal LVEF on completion of trastuzumab±anthracycline therapy at least 5 years previously. Methods Participants with human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab±anthracycline ≥5 years previously were identified from a clinical database. All participants had normal LVEF prior to, and on completion of, treatment. Participants underwent clinical cardiovascular evaluation, ECG, cardiac biomarker evaluation and CMR. Left ventricular systolic dysfunction (LVSD) was defined as LVEF <50%. Results Forty participants were recruited between 15 March 2021 and 19 July 2022. Median time
Source: heart.bmj.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 11
The 2-day official Course of APSIC is back on 21-22 September 2023 with interactive sessions, hands-on training and its Training Village Programme. Join your global, Asia Pacific Community!
Source: www.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: General Medicine News, Cardiology News and JournTweet-
“Patients who practised yoga on top of taking their medications felt better, were able to do more, & had stronger hearts than those who only took drugs for their heart failure,” said author Dr. Ajit Singh. Research was presented today at #HeartFailure2024 https://t.co/Yx0oBfSMhX https://t.co/Ao72HcrfEi
-
🌹 Roses are red, violets are blue, this Mother’s Day, let’s give back, too! Honor the moms you love and sow seeds of heart health for families by supporting lifesaving research and education. DOUBLE your gift with the Million Dollar Match for Mom. https://t.co/FLLwa18iKl https://t.co/70IbYoPhZp